The Orange Pill Podcast 🎙️ Your go-to source for the latest in the dietary supplement and natural health product industry! Brought to you by KGK Science, a global leader in clinical research and regulatory consulting, this podcast delivers: ✔️ Breaking industry news and trends ✔️ Educational insights and practical takeaways ✔️ Discussions on cutting-edge research ✔️ Landmark cases and notable events shaping the field Join us as we bridge the gap between science, regulation, and everyday impact.
Millions of people struggle with constipation, yet many still rely on laxatives that simply force the digestive system into action. In Episode 132 of the Orange Pill Podcast, we explore why fructooligosaccharides (FOS), a clinically studied prebiotic, may represent a smarter approach to digestive health. Learn how FOS nourishes beneficial gut bacteria, promotes natural bowel function, and supports long-term digestive wellness through the power of the microbiome.
Clinical trials are essential, but choosing the wrong dose, population, or endpoint can derail a study before it begins. In Episode 131 of the Orange Pill Podcast, we introduce the KGK Design Intelligence Lab and explore how in silico dietary modeling can simulate health outcomes across virtual populations before the first participant is enrolled. By combining randomized clinical trial data, NHANES population insights, and advanced statistical modeling, researchers can design smarter, more targeted, and better-informed human studies.
Can one of the world's most researched plant compounds actually improve athletic performance, or have we been asking the wrong question? In this episode of the Orange Pill Podcast, we explore the science behind quercetin, the flavonoid once hailed as an "exercise mimetic" after remarkable animal studies. Discover why early human trials largely disappointed, how new delivery technologies are changing the conversation, and why quercetin's greatest benefit may not be improving race-day performance, but helping athletes recover faster and train harder.
For decades, America's food innovation system has relied on the self-GRAS pathway, allowing companies to determine the safety of new ingredients without mandatory FDA notification. That system may be about to change. In this episode of the Orange Pill Podcast, we explore the proposed federal legislation that could fundamentally reshape how food ingredients reach the marketplace, and what it means for manufacturers, regulators, and consumers alike.
Why do two people eating the exact same meal have completely different metabolic responses? In this episode of the Orange Pill Podcast, we explore the groundbreaking PREDICT study, the largest personalized nutrition study of its kind, which challenges decades of conventional dietary advice. From your gut microbiome and meal timing to machine learning and metabolic fingerprints, discover why the future of nutrition may be far more personal than we've ever imagined.
A new Utah law is expanding the definition of "specialized products", and the implications could extend well beyond cannabinoids and nicotine. In this episode of the Orange Pill Podcast, we unpack H.B. 385, the legislation introducing new licensing, testing, and reporting requirements for products with psychoactive, sedative, or analgesic properties. From melatonin and botanicals to retailer liability and product transparency, we explore what this law could mean for the future of supplement regulation in the United States.
Feeling "fine" isn't always the same as feeling your best. In this episode of the Orange Pill Podcast, we explore groundbreaking research showing how a standardized saffron extract may improve perceived mental well-being, not by acting like an antidepressant, but by subtly reshaping the body's chemistry. From metabolomics and amino acid pathways to stress resilience and preventive mental health, this episode uncovers why the future of mood support may begin long before a clinical diagnosis.
The push to "Make America Healthy Again" promised sweeping changes to the U.S. food supply, but turning bold ideas into federal policy is proving far more complex. In this episode of the Orange Pill Podcast, we explore the growing debate around food additives, GRAS reform, food dyes, and the influence of lobbying on regulatory decision-making. As policymakers, industry, and consumer advocates collide, one question remains: how do we modernize food regulation while balancing innovation, scientific evidence, and public health?
Migraine is more than a headache- it is one of the leading causes of disability worldwide and the number one cause of disability among children and adolescents. In this episode of the Orange Pill Podcast, we explore the growing body of research linking magnesium deficiency to migraine risk, severity, and neurological health. From hidden deficiencies and energy metabolism to emergency room interventions and long-term prevention, this episode examines why one of the body's most overlooked minerals is becoming a major focus in migraine science.
We've all experienced it. The post-lunch slump. The brain fog. The sudden urge for another coffee. In this episode of the Orange Pill Podcast, we explore the emerging science behind paraxanthine, the primary metabolite of caffeine, and its potential to support focus, productivity, and satiety during the most challenging hours of the workday. From improved cognitive performance to reduced afternoon snacking, this research suggests the future of energy may be less about consuming more caffeine and more about using smarter compounds.
Millions of people turn to matcha for calm focus—but what if your morning cup isn’t delivering the benefits you expect? In this episode of the Orange Pill Podcast, we unpack the emerging science behind L-theanine, the unique amino acid responsible for matcha’s signature “relaxed alertness.” From anxiety and sleep quality to cognitive performance and the surprising chemical formula that determines whether matcha actually reduces stress, this episode explores why the right ratio may matter more than the ritual itself.
The wellness industry is evolving faster than ever. From colostrum's explosive rise and creatine's cognitive comeback to GLP-1 companion supplements and the viral growth of sea moss, consumers are moving beyond one-size-fits-all solutions toward precision wellness. In this episode of the Orange Pill Podcast, we break down the five biggest trends shaping health, supplementation, and longevity in 2026, and what they mean for consumers, brands, and the future of preventive health.
For decades, European consumers have relied on high-potency vitamins and minerals to support their health goals. That may soon change. In this episode of the Orange Pill Podcast, we explore the European Union’s plan to harmonize supplement regulations, and why proposed maximum nutrient levels could dramatically reduce the potency of many products currently on the market. From Vitamin B6 limits to mandatory reformulations, this is the regulatory shift that could reshape the future of supplementation across Europe.
Constipation affects millions of people, but what if better gut health isn’t about harsher solutions, but smarter bacteria? In this episode of the Orange Pill Podcast, we break down a new 2026 clinical trial exploring how a precision probiotic combination improved bowel regularity, stool consistency, digestive comfort, and quality of life in otherwise healthy adults. This is the shift from generic probiotics to targeted microbiome science.
For decades, folic acid has been boxed into one category: prenatal health. But Vitamin B9 may be doing much more than supporting pregnancy. In this episode of the Orange Pill Podcast, we unpack the surprising science behind folic acid, from heart health and cognition to male fertility, genetics, and why the “natural vs synthetic” debate may not be as simple as it seems. Turns out, one of nutrition’s most overlooked vitamins might actually be for everyone.
NAD+ supplements have become synonymous with longevity, but does increasing a biomarker automatically mean improving health? In this episode of the Orange Pill Podcast, we unpack the regulatory showdown over Tru Niagen®, the growing scrutiny around “clinically proven” claims, and why raising NAD+ levels may not always translate into real-world benefits. As longevity science advances, the question is shifting from Can we change biology? to Will consumers actually feel the difference?
GLP-1 medications are changing the future of obesity treatment, but rapid weight loss may be hiding a nutritional cost. In this episode of the Orange Pill Podcast, we unpack emerging evidence linking GLP-1 therapy with vitamin and mineral depletion, muscle loss, and overlooked metabolic risks. Because the goal shouldn’t just be losing weight, it should be protecting health while doing it.
GLP-1 medications are transforming obesity treatment- but rapid weight loss may come with hidden costs. In this episode of the Orange Pill Podcast, we explore the emerging science of “pharmaconutrition” and why preserving muscle, protecting gut health, and preventing metabolic rebound may be just as important as the number on the scale. From whey protein and omega-3s to gut-supportive fibers and post-GLP-1 recovery strategies, this is the nutritional blueprint for a smarter GLP-1 journey.
What if your dry, irritated eyes are signaling something deeper than screen time or aging? In this episode of the Orange Pill Podcast, we unpack new research involving 11 million adults that found vitamin D deficiency was associated with a nearly 29% higher risk of developing Dry Eye Disease. From inflammation and oxidative stress to the emerging role of the ocular microbiome, this episode explores why the future of eye health may begin with correcting systemic nutrient deficiencies.
New York just launched one of the most aggressive food safety laws in the country, and it could change the future of the American grocery aisle. In this episode of the Orange Pill Podcast, we unpack the Food Safety and Chemical Disclosure Act, the ban on controversial additives like Red No. 3 and potassium bromate, and why states are no longer waiting for federal regulators to act. From public ingredient databases to the collapse of “secret” GRAS loopholes, this is the beginning of a new era in food transparency.
